Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Amarin Corporation plc

Market Cap 320M 276M 254M 238M 446M 30.38B 453M 3B 1.17B 14.78B 1.2B 1.17B 51.19B P/E Ratio 2026 *
-435x
P/E Ratio 2027 * 277x
Enterprise Value 146M 126M 116M 109M 203M 13.85B 207M 1.37B 534M 6.74B 547M 535M 23.34B EV / Sales 2026 *
0.8x
EV / Sales 2027 * 0.68x
Free-Float
89.38%
Yield 2026 *
-
Yield 2027 * -
1 day+0.80%
1 week+4.13%
Current month+1.61%
1 month+0.80%
3 months-10.64%
6 months+4.13%
Current year+5.88%
1 week 11.8
Extreme 11.8
12.7
1 month 11.6
Extreme 11.6
12.7
Current year 11.2
Extreme 11.2
14.1
1 year 10.8
Extreme 10.8
17.2
3 years 5.92
Extreme 5.92
25.2
5 years 5.92
Extreme 5.92
101.2
10 years 5.92
Extreme 5.92
540
Manager TitleAgeSince
Chief Executive Officer 63 2024-06-03
Director of Finance/CFO 42 2024-10-22
Compliance Officer 56 2023-11-14
Director TitleAgeSince
Director/Board Member 63 2024-06-03
Director/Board Member 43 2023-02-27
Director/Board Member 67 2023-02-27
Change 5-day change 1-year change 3-year change Capi.($)
+0.80%+4.13% - - 320M
+1.03%+2.30%+54.92%+111.78% 56.42B
+2.72%+3.26%+47.26%+47.26% 44.54B
+1.12%+2.79%-13.71%-17.53% 22.9B
+1.17%+3.85%+1.00%+401.79% 21.21B
+3.81%-5.07%+12.00%-29.52% 16.4B
+0.15%+2.24%+9.10%-40.04% 15.4B
-0.69%+0.82%+27.17%+178.31% 13.35B
+5.27%+5.54%+14.25% - 12.36B
+1.61%+1.28%+92.88%+215.31% 11.15B
Average +1.70%+2.09%+27.21%+108.42% 23.75B
Weighted average by Cap. +1.72%+2.37%+31.92%+100.38%

Financials

2026 *2027 *
Net sales 182M 157M 145M 136M 254M 17.32B 258M 1.71B 668M 8.43B 684M 669M 29.19B 193M 167M 154M 144M 269M 18.34B 274M 1.81B 707M 8.93B 724M 709M 30.9B
Net income -15.02M -12.98M -11.96M -11.19M -20.97M -1.43B -21.3M -141M -55.05M -695M -56.38M -55.18M -2.41B 22.13M 19.11M 17.61M 16.49M 30.9M 2.1B 31.38M 208M 81.09M 1.02B 83.06M 81.29M 3.55B
Net Debt -174M -150M -138M -130M -243M -16.53B -247M -1.63B -637M -8.04B -653M -639M -27.85B -187M -162M -149M -140M -262M -17.82B -266M -1.76B -687M -8.67B -704M -689M -30.03B
Logo Amarin Corporation plc
Amarin Corporation PLC is a pharmaceutical company. The Company is focused on the commercialization and development of therapeutics to improve cardiovascular (CV), health and reduce CV risk. The Company operates through the development and commercialization of VASCEPA. Its lead product, Vascepa (icosapent ethyl) capsule is used as an adjunct to diet to reduce triglyceride levels in adult patients with severe hypertriglyceridemia. This indication for Vascepa, known as the MARINE indication, is based primarily on the results from the MARINE study of Vascepa in this approved patient population. The Company sells Vascepa principally to wholesalers, as well as selected regional wholesalers and specialty pharmacy providers, or collectively, its distributors, which in turn resell Vascepa to retail pharmacies for resale to patients and healthcare providers.
Employees
80
Date Price Change
26-06-12 12.60 +0.80%
26-06-11 12.50 -0.79%
26-06-10 12.60 -0.79%
26-06-09 12.70 +4.10%
26-06-08 12.20 +0.83%
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
UNDERPERFORM
Number of Analysts
2
Last Close Price
15.24USD
Average target price
12.50USD
Spread / Average Target
-17.98%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!